1. A novel immunogenic cell death-related gene risk signature can identify biomarkers of gliomas and predict the immunotherapeutic response
   Xuewu Tang, 2024, American Journal of Cancer Research CrossRef
2. Comparative Proteomics Identified EXOSC1 as a Target Protein of Anticancer Peptide LVTX-8 in Nasopharyngeal Carcinoma Cells
   Ganghua Zhu et al, 2024, Journal of Proteome Research CrossRef
3. Machine learning‐based identification of a cell death‐related signature associated with prognosis and immune infiltration in glioma
   Quanwei Zhou et al, 2024, Journal of Cellular and Molecular Medicine CrossRef
4. Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor-kappa B signaling pathway
   Ruihua Fan et al, 2022, Frontiers in Molecular Neuroscience CrossRef
5. The indispensability of macrophage adaptor proteins in chronic inflammatory diseases
   Rajat Atre et al, 2023, International Immunopharmacology CrossRef
6. A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma
   Jianhua Zhang et al, 2023, PeerJ CrossRef
7. Antiatherosclerotic effects of corilagin via suppression of the LOX-1/MyD88/NF-κB signaling pathway in vivo and in vitro
   Bo He et al, 2022, Journal of Natural Medicines CrossRef
8. Network-Based Elaboration of the Efficacy of the Dachangshu (BL25) and Tianshu (ST25) Points in the Treatment of Functional Constipation in Children through Inflammation, Adipocytokine, or Leptin Pathways
   Yan Xu et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
9. AC099850.3 promotes HBV-HCC cell proliferation and invasion through regulating CD276: a novel strategy for sorafenib and immune checkpoint combination therapy
   Aoxiao He et al, 2024, Journal of Translational Medicine CrossRef
10. TLR4/ MyD88/NF-κB signaling pathway involved in the protective effect of diacerein against lung fibrosis in rats
    Asmaa Mohamed Abdel-Aziz et al, 2023, Human & Experimental Toxicology CrossRef
11. The potential of activator protein 1 (AP-1) in cancer targeted therapy
    Dandan Song et al, 2023, Frontiers in Immunology CrossRef
12. Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
    Suprabhat Mukherjee et al, 2023, Frontiers in Immunology CrossRef
13. Targeting MALT1 Suppresses the Malignant Progression of Colorectal Cancer via miR-375/miR-365a-3p/NF-κB Axis
    Rui Qian et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
14. MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas
    Qinglong Guo et al, 2021, Frontiers in Oncology CrossRef
15. Direct interaction of the molecular chaperone GRP78/BiP with the Newcastle disease virus hemagglutinin-neuraminidase protein plays a vital role in viral attachment to and infection of culture cells
    Chenxin Han et al, 2023, Frontiers in Immunology CrossRef
16. MiR-525-5p inhibits diffuse large B cell lymphoma progression via the Myd88/NF-κB signaling pathway
    Xiuchen Guo et al, 2023, PeerJ CrossRef
17. GRB7-mediated enhancement of cell malignant characteristics induced by Helicobacter pylori infection
    Huilin Zhao et al, 2024, Frontiers in Microbiology CrossRef
18. null
    , 2024, CrossRef